Brazil currently has one of the fastest-growing severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) epidemics in the world. Because of limited available data, assessments …

Mitigating global infectious disease requires diagnostic tools that are sensitive, specific, and
rapidly field deployable. In this study, we demonstrate that the Cas13-based SHERLOCK (…

The first case of COVID-19 was detected in Brazil on 25 February 2020. We report and
contextualize epidemiological, demographic and clinical findings for COVID-19 cases during the …

The clinical outcomes associated with Zika virus (ZIKV) in the Americas have been well
documented, but other aspects of the pandemic, such as attack rates and risk factors, are poorly …

During ZIKV the outbreak in Brazil it was observed an increase of almost 20 times the number
of reported cases of microcephaly in newborn babies. There is no vaccine or approved …

Aedes aegypti and A. albopictus mosquitoes are the main vectors for dengue virus (DENV)
and other arboviruses, including Zika virus (ZIKV). Understanding the factors that affect …

The recent Zika virus (ZIKV) outbreak demonstrates that cost-effective clinical diagnostics
are urgently needed to detect and distinguish viral infections to improve patient care. Unlike …

Zika virus (ZIKV) has been associated to central nervous system (CNS) harm, and virus was
detected in the brain and cerebrospinal fluids of microcephaly and meningoencephalitis …

Background Butantan–Dengue Vaccine (Butantan-DV) is an investigational, single-dose, live,
attenuated, tetravalent vaccine against dengue disease, but data on its overall efficacy are …

Background Nosocomial infections caused by Pseudomonas aeruginosa presenting resistance
to beta-lactam drugs are one of the most challenging targets for antimicrobial therapy, …